Resources

Dr. Barbara E. Corkey talks about the huge amount of misinformation on the internet regarding substances that may or not cause diabetes. She points out that most of what we know is actually based on correlation rather than solid evidence and cites the example of the U.S. government’s decision to …

Dr. Barbara E. Corkey, talks about how the current dogma on how our obese patients should lose weight to combat diabetes is simply not working. She notes that we seem to be focusing too much on the wrong things – sending patients home with the advice to lose weight – …

In this week’s Homerun Slides from Dr. Stanley Schwartz, we look into exactly what a more aggressive therapy towards treating diabetes might look like with a review of dual and triple therapy approaches as well as which medications can be used and when. We also examine the cardiovascular impact of these …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP There is a steep age-related increase in the prevalence of diabetes and impaired glucose tolerance which applies equally to both sexes. Overall, diabetes prevalence is higher in men, but there are more women with diabetes. In devel­oping countries, most people with diabetes …

The Endocrine Society has released a clinical practice guideline on the pharmacological management of obesity that includes recommendations on strategies for prescribing weight loss drugs.

An ultra-thin, flexible sensor that sticks to the skin like a temporary tattoo can detect a person’s blood glucose levels… “The sensor represents the first example of an easy-to-wear flexible tattoo-based epidermal diagnostic device combining reverse iontophoretic extraction of interstitial glucose and an enzyme-based amperometric biosensor,” the researchers wrote. In …

The FDA has approved the Maestro Rechargeable System for treatment of obesity… The Maestro Rechargeable System is indicated for treatment of patients aged at least 18 years with a BMI of 35 to 45 with at least one obesity-related condition and who have failed to lose weight on a weight …

According to a new retrospective study acarbose may not have a cardioprotective effect as good as metformin when used as first-line therapy… This study analyzed 17,366 patients who initiated acarbose therapy and 230,023 who initiated metformin therapy. Both nephropathy and diabetes complication severity index were strongly associated with the patients …

In the study, the older athletes’ physical functions were more similar to that of young adults than of people their age… In a cross-sectional cohort study, researchers measured the relationship between age and physiological activity in healthy older individuals. The study included 84 male and 41 female cyclists aged 55 …

For every 0.56 mmol/L increase in fasting blood glucose there was a 14% increase in the rate of pancreatic cancer… In previous studies, an assumption has been made that diabetes may be either a risk factor or a symptom of pancreatic cancer. To investigate this connection, researchers examined both linear …